SARS-CoV-2 vaccine (an interval of two doses) | 1 M | 2 M | 3 M | |||
---|---|---|---|---|---|---|
Median | SR | Median | SR | Median | SR | |
BBIBP-CorV (4 weeks) | 70.49 (n = 10) | 100% | 78.43 (n = 11) | 91% | 29.17 (n = 15) | 80% |
BBIBP-CorV (8 weeks) | 73.97 (n = 6) | 100% | 38.21 (n = 30) | 87% | 29.85 (n = 13) | 77% |
CoronaVac (4 weeks) | 109.31 (n = 14) | 100% | 79.4 (n = 23) | 96% | / | / |
CoronaVac (8 weeks) | 299.7 (n = 14) | 100% | 82.92 (n = 20) | 100% | / | / |
X2 | 8.977 | / | 12.344 | / | / | / |
P | 0.03* | / | 0.006* | / | 0.235 | / |